Trial · NCT02287025
Adverse events105
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 105
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANEMIA | Blood and lymphatic system disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Regorafenib (Stivarga, BAY 73-4506) | 2 | 19 | 5 |
| other | HYPOTHYROIDISM | Endocrine disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | BLURRED VISION | Eye disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 2 |
| other | CONJUNCTIVITIS | Eye disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 6 | 19 | 7 |
| other | CONSTIPATION | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 7 | 19 | 8 |
| other | DIARRHEA | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 9 | 19 | 21 |
| other | DRY MOUTH | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 2 | 19 | 2 |
| other | DYSPHAGIA | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | FLATULENCE | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | GASTROESOPHAGEAL REFLUX DISEASE | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | LIP SWELLING | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 2 |
| other | NAUSEA | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 7 | 19 | 8 |
| other | OROPHARYNGEAL CONDITIONS | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | PROCTITIS | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 2 |
| other | SORES MOUTH | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 2 | 19 | 2 |
| other | STOOL DISCOLORED | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 1 | 19 | 1 |
| other | VOMITING | Gastrointestinal disorders | Regorafenib (Stivarga, BAY 73-4506) | 5 | 19 | 6 |
| other | ASTHENIA | General disorders | Regorafenib (Stivarga, BAY 73-4506) | 2 | 19 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02287025/events